Litcius/Paper detail

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Florian Bouclet, Anne Calleja, Marie‐Sarah Dilhuydy, Lauren Véronèse, Bruno Pereira, Sandy Amorim, Florence Cymbalista, Charles Herbaux, Sophie de Guibert, Damien Roos‐Weil, Bénédicte Hivert, Thérèse Aurran, Jehan Dupuis, Anaïse Blouet, Emmanuelle Tchernonog, Kamel Laribi, Nataliya Dmytruck, Pierre Morel, Anne‐Sophie Michallet, Caroline Dartigeas, Olivier Tournilhac, Florence Nguyen‐Khac, Alain Delmer, Pierre Feugier, Loïc Ysebaert, Romain Guièze

2021Annals of Hematology32 citationsDOI

Topics & Concepts

VenetoclaxMedicineHematologyChronic lymphocytic leukemiaInternal medicineCohortOncologyLeukemiaChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and Treatment
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort | Litcius